Northwest & Ethical Investments’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-68,643	Closed	-$2M	–	524
2024 Q3	$2M	Sell	68,643 -7,192	-9%	-$178K	0.05%	251
2024 Q2	$1.76M	Hold	75,835	–	–	0.05%	257
2024 Q1	$1.56M	Buy	75,835 +4,551	+6%	+$85.5K	0.04%	265
2023 Q4	$1.53M	Sell	71,284 -3,484	-5%	-$69K	0.05%	251
2023 Q3	$1.54M	Hold	74,768	–	–	0.05%	249
2023 Q2	$2.21M	Sell	74,768 -17,729	-19%	-$498K	0.07%	240
2023 Q1	$2.13M	Sell	92,497 -2,366	-2%	-$65.1K	0.07%	252
2022 Q4	$2.64M	Buy	94,863 +14,983	+19%	+$446K	0.09%	217
2022 Q3	$2.45M	Hold	79,880	–	–	0.1%	216
2022 Q2	$2.35M	Hold	79,880	–	–	0.09%	221
2022 Q1	$2.57M	Buy	79,880 +48,280	+153%	+$1.66M	0.08%	229
2021 Q4	$1.41M	Buy	+31,600	New	+$1.5M	0.04%	267